Based on the information provided by the previous literatures, LINC00649 acted as an oncogene to facilitate the development of acute myeloid leukemia (AML) [10,11], prostate cancer [12] and colorectal cancer [13], but it was still unclear whether LINC00649 modulated GC progression in a similar manner. Here, LINC00649 is linked to prostate carcinoma.